Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Cope

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.
Immunology Letters|June 15, 2007
Nitric oxide, chronic inflammation and autoimmunityGyörgy Nagy, Joanna M Clark, Edit I Buzás, et al.
Blood|November 1, 2007
Strontium can increase some osteoblasts without increasing hematopoietic stem cellsStefania Lymperi, Nicole Horwood, Stephen Marley, et al.
The Lancet. Respiratory Medicine|November 6, 2022
Moving the pathway goalposts: COPD as an immune-mediated inflammatory diseaseSteven P Cass, Andrew P Cope, Dan V Nicolau, et al.
Rheumatology (Oxford, England)|January 5, 2013
The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysisIan C Scott, Rachael Tan, Daniel Stahl, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alphaJoanna M Clark, Alexander E Annenkov, Manvinder Panesar, et al.
The Journal of Rheumatology|June 17, 2014
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimenMargaret H Y Ma, Ian C Scott, Chanaka Dahanayake, et al.
Nature Reviews. Rheumatology|October 9, 2023
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?Hanna W van Steenbergen, Andrew P Cope, Annette H M van der Helm-van Mil
Rheumatology (Oxford, England)|October 7, 2020
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Rheumatology (Oxford, England)|January 31, 2020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.
Immunology Letters|June 15, 2007
Nitric oxide, chronic inflammation and autoimmunityGyörgy Nagy, Joanna M Clark, Edit I Buzás, et al.
Blood|November 1, 2007
Strontium can increase some osteoblasts without increasing hematopoietic stem cellsStefania Lymperi, Nicole Horwood, Stephen Marley, et al.
The Lancet. Respiratory Medicine|November 6, 2022
Moving the pathway goalposts: COPD as an immune-mediated inflammatory diseaseSteven P Cass, Andrew P Cope, Dan V Nicolau, et al.
Rheumatology (Oxford, England)|January 5, 2013
The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysisIan C Scott, Rachael Tan, Daniel Stahl, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alphaJoanna M Clark, Alexander E Annenkov, Manvinder Panesar, et al.
The Journal of Rheumatology|June 17, 2014
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimenMargaret H Y Ma, Ian C Scott, Chanaka Dahanayake, et al.
Nature Reviews. Rheumatology|October 9, 2023
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?Hanna W van Steenbergen, Andrew P Cope, Annette H M van der Helm-van Mil
Rheumatology (Oxford, England)|October 7, 2020
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Rheumatology (Oxford, England)|January 31, 2020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Pageof 14